LUGPA Policy Alert - CY 2027 Medicare Physician Fee Schedule (MPFS) Final Rule
November 2026
At a Glance
CMS finalized the CY 2027 MPFS Final Rule on November 4, 2026, with changes affecting physician reimbursement, practice expenses, E/M services, and quality reporting. Key provisions include a 1.83%–2.31% reduction in conversion factors, a 20% payment reduction for certain separately identifiable E/M services furnished on the same day as procedures with 0-day global periods, and the transition from traditional MIPS reporting beginning in 2031.
Background
On November 4, CMS finalized the CY 2027 Medicare Physician Fee Schedule (MPFS), introducing changes to physician reimbursement, quality reporting, and Medicare payment policies. The rule emphasizes preventive care, coordinated services, and reducing duplicative billing.
For independent urology practices, key provisions include lower Medicare conversion factors, changes to payment for separately identifiable E/M services furnished alongside procedures with 0-day global periods, revisions to practice expense calculations, and the eventual elimination of traditional MIPS reporting.
Key Finalized Provisions
1. Conversion Factor and Medicare Physician Payment
CMS finalized the following CY 2027 Medicare Physician Fee Schedule conversion factors:
|
Payment Category
|
CY 2026
|
CY 2027 Final
|
Change
|
|
Non-QP Participants
|
$33.40
|
$32.63
|
-2.31%
|
|
Qualifying APM Participants (QP)
|
$33.57
|
$32.95
|
-1.83%
|
- The non-QP conversion factor decreases by $0.77, or 2.31%.
- The QP conversion factor decreases by $0.62, or 1.83%.
- Both factors reflect the expiration of the one-time 2.5% statutory payment increase for CY 2026, partially offset by permanent statutory updates for CY 2027.
Urology Impact: Lower conversion factors continue to place pressure on Medicare physician reimbursement. Combined with rising practice expenses and other payment adjustments, these reductions reinforce the need for sustainable physician payment reform.
2. Same-Day E/M Services and Payment Policy
- Reduces payment to 80% for the lower-valued service when a separately identifiable office/outpatient E/M service and one or more procedures with 0-day global periods are furnished on the same day by the same physician or a physician in the same practice.
- The highest-valued service is paid at 100%, while the other applicable E/M service(s) or procedure(s) are paid at 80%.
- The finalized policy applies only to 0-day global procedures, excluding the 10- and 90-day global procedures included in CMS's original proposal.
- Modifier 25 remains available when applicable billing requirements are met.
Urology Impact: The policy could affect reimbursement when urologists furnish separately identifiable E/M services alongside procedures with 0-day global periods. Practices should review their procedure mix, coding practices, and potential reimbursement implications.
3. Physician Payment and Practice Expense Methodology
- Phases out the indirect practice cost index (IPCI) over two years.
- Introduces a practice expense stabilization adjustment to help mitigate short-term payment volatility.
- Changes how indirect practice expenses are allocated when calculating physician payment rates.
- Reduces reliance on historical specialty-specific practice expense data in determining indirect practice expenses.
Urology Impact: Changes to indirect practice expense calculations could redistribute Medicare payments among specialties and services. Independent practices should monitor the impact on office-based procedures and other services that depend on accurate recognition of practice overhead.
4. G2211 Transition and E/M Payment Modifiers
- Replaces the existing G2211 E/M visit complexity add-on code with Modifier B1, increasing payment for the associated E/M service by 16%.
- Establishes Modifier B2 for eligible practitioners participating in Medicare Shared Savings Program ACOs or the LEAD Model, increasing payment for the associated E/M service by 32%.
- Use of the new modifiers is voluntary and subject to applicable billing requirements.
Urology Impact: The new modifiers create potential payment opportunities for eligible practices, particularly those participating in qualifying ACO arrangements. Practices should review implementation guidance and applicable billing requirements.
5. Quality Payment Program (QPP)
- Ends traditional MIPS reporting beginning with the CY 2031 performance period.
- Allows clinicians through CY 2030 to transition to MIPS Value Pathways (MVPs) or Advanced APMs.
- Establishes three new MVPs focused on diabetes, hypertension, and hospitalists.
- Beginning with the CY 2027 performance period, generally requires clinicians participating in traditional MIPS or MVP reporting to report at least one applicable MIPS Core Measure. Clinicians reporting a specialty or subspecialty measure set must select an applicable measure from that set. Small practices are exempt from this requirement.
Urology Impact: The transition gives practices additional time to prepare for changes to quality reporting. Specialty-appropriate measures will remain important to ensuring that urology practices are evaluated using relevant clinical and performance standards.
6. Medicare Shared Savings Program
- Allows approved ACOs to reduce or eliminate certain Medicare Part B beneficiary cost-sharing obligations for assigned beneficiaries beginning April 1, 2027, subject to CMS approval.
- Expands opportunities for ACOs to provide beneficiary financial support through approved arrangements.
- Updates shared savings incentives and streamlines certain reporting and administrative requirements.
Urology Impact: These changes may create additional opportunities for independent urology practices participating in qualifying ACO arrangements and other coordinated care initiatives. ACOs must receive CMS approval to implement these arrangements. The flexibility excludes durable medical equipment, prosthetics, orthotics, supplies (DMEPOS), and prescription drugs.
7. Preventive Care and Additional Services
- Establishes separate coding and payment for shared medical appointments, including an additional-time billing code.
- Finalizes increases in valuations for smoking cessation and tobacco-use services and structured assessment, brief intervention, and referral to treatment (SBIRT).
- Establishes two new Advance Care Planning billing codes (G0572 and G0573) for qualifying services furnished by clinical staff under direct supervision.
- Updates payment valuations for Psychiatric Collaborative Care Model services.
Urology Impact: Practices should review applicable coding and payment opportunities, particularly for shared medical appointments and advance care planning services for patients with complex or advanced conditions.
8. Ambulatory Specialty Model
- Finalizes refinements to the Ambulatory Specialty Model (ASM), scheduled to launch January 1, 2027.
- Focuses on specialist management of heart failure and low back pain.
- Emphasizes quality, longitudinal management, and total cost of care.
Urology Impact: Although urology is not among the initial targeted specialties, the model reflects CMS's continued movement toward specialty accountability and value-based payment.
LUGPA Perspective
LUGPA supports efforts to improve payment accuracy, reduce administrative burdens, and promote coordinated care. However, Medicare payment policies must recognize the resources required to deliver specialty care in independent, community-based settings.
The lower CY 2027 conversion factors, changes to indirect practice expense calculations, and finalized same-day E/M payment reduction are particularly important for urology practices. Urologists frequently furnish separately identifiable evaluation and management services alongside office-based procedures, making appropriate reimbursement essential to maintaining access to community-based specialty care.
LUGPA will continue to monitor the impact of these policies and advocate for payment reforms that support independent, physician-led practices.
Additional Resources:
|